Loading people...
Greg Madden is a Managing Partner at SV Health Investors, a prominent venture capital firm specializing in healthcare and life sciences investments. He plays a key leadership role in identifying and supporting innovative companies in the sector.
Greg Madden primarily invests in companies within the healthcare and life sciences sectors. His focus areas include biotechnology, pharmaceuticals, medical devices, digital health, and healthcare services, seeking out disruptive technologies and solutions.
Greg Madden works at SV Health Investors, where he serves as a Managing Partner. SV Health Investors is a leading venture capital firm with offices in both the US and UK, dedicated to advancing healthcare innovation.
Greg Madden is a Managing Partner at SV Health Investors in the Greater Boston Area, where he co-leads the firm's Healthcare Growth fund. Since joining the firm as an Analyst in 2002, he has spent over two decades managing medical device and healthcare services investments for the venture capital firm, which oversees more than $2.7 billion in total assets under management. Prior to his tenure at SV Health Investors, he worked in the emerging technology and private equity groups at the law firm Testa, Hurwitz & Thibeault, supporting venture funds in mergers, acquisitions, and financings. He holds a Bachelor of Arts with honors from Colby College and a Master of Business Administration with high honors from Boston University. Madden currently focuses on guiding portfolio companies through strategic operations and successful exits, including the acquisition of Aligned Telehealth by Amwell.
Greg Madden stands as a pivotal figure in the healthcare investment landscape, serving as a Managing Partner at SV Health Investors. In this influential role, he is instrumental in steering the firm's strategic direction and identifying high-potential opportunities within the dynamic life sciences and healthcare sectors. SV Health Investors is renowned for its deep expertise and long-standing commitment to fostering innovation that addresses critical unmet medical needs, and Madden's leadership is central to this mission.
As a Managing Partner, Greg Madden's responsibilities encompass a broad spectrum of activities crucial to successful venture capital. He is deeply involved in deal sourcing, meticulously evaluating potential investments, and conducting thorough due diligence. His keen eye for disruptive technologies and scalable business models allows SV Health Investors to back companies poised for significant impact. Furthermore, Madden provides invaluable strategic guidance to portfolio companies, helping them navigate complex development pathways, achieve key milestones, and ultimately bring transformative solutions to patients worldwide.
Greg Madden's investment focus aligns perfectly with SV Health Investors' core strengths, spanning a wide array of healthcare sub-sectors. This includes cutting-edge biotechnology and pharmaceutical companies developing novel therapeutics, innovative medical device firms creating next-generation diagnostic and treatment tools, and pioneering digital health ventures leveraging technology to improve patient care and access. His expertise helps the firm identify opportunities that not only promise strong financial returns but also hold the potential for profound societal benefit.
Throughout his distinguished career, Greg Madden has cultivated a robust background in finance and venture capital, with a specialized emphasis on the healthcare industry. His journey into healthcare investment has equipped him with a comprehensive understanding of the scientific, regulatory, and commercial complexities inherent in bringing new medical innovations to market. This deep sector knowledge, combined with his strategic acumen, enables him to effectively assess risks and opportunities, making him a trusted advisor to entrepreneurs and a respected leader among his peers.
While specific individual investments are often part of a broader firm portfolio, Greg Madden has been instrumental in numerous successful investments within the healthcare and life sciences space. His contributions have helped to nurture and grow companies that are developing life-changing therapies, improving healthcare delivery, and advancing medical science. His work at SV Health Investors continues to solidify the firm's reputation as a leader in healthcare venture capital, driving progress and delivering value through strategic, impactful investments.
